Long-Term Cardiac Safety Analysis of NCCTG N9831 (Alliance) Adjuvant Trastuzumab Trial Advani, Pooja P. , Ballman, Karla V. , Dockter, Travis J. ... - - J. Clin. Oncol - 2016 Manuscript - Primary - Long-Term-Followup - Breast - N9831
Long-term cardiac safety analysis of NCCTG (Alliance) N9831 adjuvant trastuzumab (H) trial. Advani, Pooja Prem , Ballman, Karla V. , Dockter, Travis J. ... - ASCO - J. Clin. Oncol. - 2014 Abstract - Primary - Long-Term-Followup - Breast - N9831
Comparative Age-Based Prospective Multi-Institutional Observations from 12,367 Patients Enrolled to American College of Surgeons Oncology Group (ACOSOG Z901101) Trials (Alliance) Al-Refaie, Waddah B. , Decker, Paul A. , Ballman, Karla V. ... - - Ann. Surg. Oncol. - 2019 Manuscript - Secondary-not-in-original - Meta-Analysis - Older Adult - Z901101
Attributes and Outcomes of Older Adults in Surgical Oncology Trials: Results from ACOSOG Z901101 (Alliance) Al-Refaie, Waddah B. , Decker, Paul A. , Pisters, Peter W.T. ... - SSO - Ann. Surg. Oncol. - 2015 Abstract - Secondary-not-in-original - Comprehensive - Older Adult - Z901101
Validating RNAseq-Signatures of Vorinostat (VOR) Sensitivity and Resistance in Patients with Newly Diagnosed Glioblastoma (GBM) Treated with VOR, Temozolomide and Radiation Therapy From Alliance N0874/ABTC-0902. Anderson, S. Keith , Miller, C. Ryan , Sarkaria, Jann N. ... - ASCO - J. Clin. Oncol. - 2016 Abstract - Secondary - Primary - Neuro-Onc - N0874 , ABTC-0902
Alliance A031501: Phase III Randomized Adjuvant Study of MK-3475 (Pembrolizumab) in Muscle Invasive and Locally Advanced Urothelial Carcinoma (MIBC) (AMBASSADOR) vs Observation Apolo, Andrea , Rosenberg, Jonathan , Morris, Michael ... - ASCO GU - J Clin Oncol - 2019 Abstract - No-Endpoint - Trial-Description-Only - GU - A031501
Lymphedema symptoms and limb measurement changes in breast cancer survivors treated with neoadjuvant chemotherapy and axillary dissection: Results of ACOSOG (American College Of Surgeons Oncology Group) Z1071 (Alliance) Substudy Armer, Jane M. , Ballman, Karla V. , McCall, Linda , Armer, Nathan C. ... - - Support Care Cancer - 2019 Manuscript - Secondary - Primary - Breast - ACOSOG-Z1071
Factors Associated With Lymphedema in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Axillary Dissection Armer, Jane M. , Ballman, Karla V. , McCall, Linda , Ostby, Pamela L. ... - ILF - JAMA Surg - 2019 Abstract - Secondary-not-in-original - Primary - Breast - ACOSOG-Z1071
Factors Associated With Lymphedema in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Axillary Dissection Armer, Jane M. , Ballman, Karla V. , McCall, Linda , Ostby, Pamela L. ... - - JAMA Surg - 2019 Manuscript - Secondary - Primary - Breast - ACOSOG-Z1071
Lymphedema results of Alliance Z1071 (American College of Surgeons Oncology Group [ACOSOG]): Self-reported symptoms and limb volume changes for breast cancer survivors treated with neoadjuvant chemotherapy and axillary dissection Armer, Jane M. , Ballman, Karla , McCall, Linda , Suman, Vera ... - ILF - - 2018 Abstract - Secondary - Primary - Breast - ACOSOG-Z1071
Symptoms and limb changes for breast cancer survivors treated with neoadjuvant chemotherapy: Lymphedema results of ACOSOG Z1071 (Alliance) Armer, Jane M. , Ballman, Karla , McCall, Linda , Suman, Vera ... - MASCC / ISOO - Supportive Cancer Care - 2017 Abstract - Secondary - Primary - Breast - ACOSOG-Z1071
The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme Ballman, Karla V. , Buckner, Jan C. , Brown, Paul D. ... - - Neuro-oncol - 2007 Manuscript - Primary - Primary - Neuro-Onc - N047D
Axillary Ultrasound After Neoadjuvant Chemotherapy and Its Impact on Sentinel Lymph Node Surgery: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance) Boughey, Judy C. , Ballman, Karla V. , Hunt, Kelly K. ... - - J. Clin. Oncol - 2015 Manuscript - Secondary - Primary - Breast - ACOSOG-Z1071
Identification and resection of the clipped node decreases the false negative rate of sentinel lymph node surgery in patients presenting with node positive breast cancer (T0-T4, N1-2) who receive neoadjuvant chemotherapy – results from ACOSOG Z1071 (Alliance) Boughey, Judy C. , Ballman, Karla V. , Le-Petross, Huong T. ... - - Ann. Surg. - 2016 Manuscript - Secondary-not-in-original - Primary - Breast - ACOSOG-Z1071
Tumor Biology and Response to Chemotherapy Impact Breast Cancer-Specific Survival in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Long-term Follow-up from ACOSOG Z1071 (Alliance) Boughey, Judy C. , Ballman, Karla V. , McCall, Linda M. ... - - Ann. Surg. - 2017 Manuscript - Secondary - Primary - Breast - ACOSOG-Z1071
Methods impacting the false negative rate of sentinel lymph node surgery in patients presenting with node positive breast cancer (T0-T4,N1-2) who receive neoadjuvant chemotherapy–results from a prospective trial–ACOSOG Z1071 (Alliance) Boughey, Judy C. , Ballman, Karla V. , Symmans, William F. ... - SABCS - Cancer Res - 2015 Abstract - Secondary - Primary - Breast - ACOSOG-Z1071
Axillary Ultrasound after Neoadjuvant Chemotherapy in Patients Presenting with Node-Positive Breast Cancer (T0-T4, N1-2, M0) and its Impact on Sentinel Lymph Node Surgery in ACOSOG Z1071 (Alliance) Boughey, Judy C. , Ballman, Karla , Hunt, Kelly K. , McCall, Linda M. ... - SIS - Journal of the Senologic International Society - 2014 Abstract - Secondary - Primary - Breast - ACOSOG-Z1071
Tumor biology and response to chemotherapy impact breast cancer specific survival in node positive breast cancer treated with neoadjuvant chemotherapy and axillary dissection: Results from ACOSOG Z1071 (Alliance) Boughey, Judy C. , Ballman, Karla , McCall, Linda , Byrd, David ... - ASA - - 2017 Abstract - Secondary - Long-Term-Followup - Breast - ACOSOG-Z1071
Factors associated with lymphedema in patients/women with node positive breast cancer treated with neoadjuvant chemotherapy and axillary dissection on a prospective clinical trial (Alliance) ACOSOG Z1071 Boughey, Judy C. , Ballman, Karla , McCall, Linda , Kuerer, Henry ... - ASCO - J Clin Oncol - 2018 Abstract - Secondary - Primary - Breast - ACOSOG-Z1071
Predictors of locoregional recurrence after neoadjuvant chemotherapy and surgery for node positive breast cancer: Results from ACOSOG Z1071 (Alliance) Boughey, Judy C. , Ballman, Karla , McCall, Linda ... - SABCS - Cancer Res. - 2017 Abstract - Secondary-not-in-original - Primary - Breast - ACOSOG-Z1071
Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) prospective multicenter clinical trial Boughey, Judy C. , McCall, Linda M. , Ballman, Karla V. ... - - Ann. Surg. - 2014 Manuscript - Secondary - Primary - Breast - ACOSOG-Z1071
Effect of the use of immediate reconstruction on the rates of bilateral mastectomy and adjuvant radiation therapy use in women with node-positive breast cancer treated with neoadjuvant chemotherapy on ACOSOG Z1071 (Alliance). Boughey, Judy C. , McCall, Linda , Haffty, Bruce , Buchholz, Tom ... - ASCO - J. Clin. Oncol. - 2015 Abstract - Secondary-not-in-original - Primary - Breast - ACOSOG-Z1071
Long term outcomes from intergroup NCCTG 86-72-51 (Alliance): Final report of a phase III prospective randomized trial of high dose versus low dose radiation therapy in adults with supratentorial low-grade glioma. Breen, William G. , Anderson, S. Keith , Carrero, Xiomara W ... - SNO - Neuro-Oncology - 2019 Abstract - Primary - Long-Term-Followup - Neuro-Onc - NCCTG-85-72-51
Final report from Intergroup NCCTG 86-72-51 (Alliance): a phase III randomized clinical trial of high-dose versus low-dose radiation for adult low-grade glioma Breen, William G , Anderson, S Keith , Carrero, Xiomara W ... - - Neuro-oncology - 2020 Manuscript - Primary - Long-Term-Followup - Neuro-Onc - NCCTG-86-72-51
NCCTG N0574 (Alliance): A Phase III Randomized Trial of Whole Brain Radiation Therapy (WBRT) in Addition to Radiosurgery (SRS) in Patients with 1 to 3 Brain Metastases. Brown, Paul D. , Asher, Anthony L. , Ballman, Karla V. ... - SNO - Neuro Oncol - 2015 Abstract - Primary - Primary - Neuro-Onc - N0574
NCCTG N0574 (Alliance): A Phase III Randomized Trial of Whole Brain Radiation Therapy (WBRT) in Addition to Radiosurgery (SRS) in Patients with 1 to 3 Brain Metastases Brown, Paul D. , Asher, Anthony L. , Ballman, Karla V. ... - ASCO - J. Clin. Oncol. - 2015 Abstract - Primary - Primary - Neuro-Onc - N0574
N107C/CEC.3 (Alliance/NCIC): Phase III Trial of Post-Surgical Stereotactic Radiosurgery (SRS) Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease Brown, Paul D. , Ballman, Karla V. , Cerhan, Jane H. ... - ASTRO - Int. J. Radiat. Oncol. Biol. Phys. - 2016 Abstract - Primary - Primary - Neuro-Onc - N107C
Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases Brown, Paul D. , Jaeckle, Kurt , Ballman, Karla V. , Farace, Elana ... - - JAMA - 2016 Manuscript - Primary - Primary - Neuro-Onc - N0574
Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial Brown, Paul D , Ballman, Karla V , Cerhan, Jane H , Anderson, S Keith ... - - Lancet Oncol. - 2017 Manuscript - Primary - Primary - Neuro-Onc - N107C
Prognosis in patients with anaplastic oligoastrocytoma is associated with histologic grade. Buckner, Jan C , O'Fallon, Judith R , Dinapoli, Robert P ... - - J. Neurooncol. - 2007 Manuscript - Primary - Primary - Neuro-Onc - NCCTG-94-72-52
Multi-Institutional Prospective Validation of Prognostic mRNA Signatures in Early Stage Squamous Lung Cancer (Alliance). Bueno, Raphael , Richards, William G , Harpole, David H ... - - J Thorac Oncol - 2020 Manuscript - Primary - Meta-Analysis - Correl Sci NOS - CALGB-150807 , CALGB-140202
Stereotactic Radiosurgery with or without Whole Brain Radiotherapy for Limited Brain Metastases: A Secondary Analysis of the NCCTG N0574 (Alliance) Randomized Controlled Trial Churilla, Thomas M. , Ballman, Karla V. , Brown, Paul D. ... - - Int. J. Radiat. Oncol. Biol. Phys. - 2017 Manuscript - Secondary - Primary - Neuro-Onc - N0574
Pathologic and Molecular Features Correlate With Long-Term Outcome After Adjuvant Therapy of Resected Primary GI Stromal Tumor: The ACOSOG Z9001 Trial Corless, Christopher L. , Ballman, Karla V. , Antonescu, Cristina R. ... - - J. Clin. Oncol - 2014 Manuscript - Secondary - Primary - GI - ACOSOG-Z9001
The Feasibility of Radiotherapy after Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial. Cuttino, Laurie , McCall, Linda , Kubicky, C , Ballman, Karla ... - ASTRO - International Journal of Radiation Oncology • Biology • Physics - 2019 Abstract - Secondary - Primary - Prevention - Z11102
Number of Lymph Nodes Harvested From a Mediastinal Lymphadenectomy Darling, Gail E. , Allen, Mark S. , Decker, Paul A. , Ballman, Karla ... - - Chest - 2011 Manuscript - Secondary-not-in-original - Primary - Respiratory - ACOSOG-Z0030
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient with N0 or N1 (Less Than Hilar) Non-Small Cell Carcinoma: Results of the ACOSOG Z0030 Trial Darling, Gail E. , Allen, Mark S. , Decker, Paul A. , Ballman, Karla ... - - J. Thorac. Cardiovasc. Surg. - 2011 Manuscript - Primary - Primary - Respiratory - ACOSOG-Z0030
Long-term results of adjuvant imatinib mesylate in localized, high-risk, primary gastrointestinal stromal tumor (GIST): ACOSOG Z9000 (Alliance) intergroup phase 2 trial DeMatteo, Ronald P. , Ballman, Karla V. , Antonescu, Cristina R. ... - - Ann. Surg. - 2013 Manuscript - Primary - Long-Term-Followup - GI - ACOSOG-Z9000
Placebo-Controlled Randomized Trial of Adjuvant Imatinib Mesylate Following the Resection of Localized, Primary Gastrointestinal Stromal Tumor (GIST) DeMatteo, Ronald P. , Ballman, Karla V. , Antonescu, Cristina R. ... - - Lancet - 2009 Manuscript - Primary - Primary - GI - ACOSOG-Z9001
Breast lymphedema following breast conservation surgery and radiation for multiple ipsilateral breast cancer: Data from the Alliance Z11102 Study Degnim, Amy C. , Ballman, Karla V. , McCall, Linda , Hoskin, Tanya L. ... - ASBrS - The American Society of Breast Surgeons' Official Proceedings - 2020 Abstract - Secondary - Primary - Breast - Z11102
Impact of c-MYC Protein Expression on Outcome of Patients with Early-Stage HER2+ Breast Cancer Treated with Adjuvant Trastuzumab NCCTG (Alliance) N9831 Dueck, Amylou C. , Reinholz, Monica M. , Geiger, Xochiquetzal J. ... - - Clin. Cancer Res. - 2013 Manuscript - Secondary - Primary - Breast - N9831
Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907 Freedman, Rachel A. , Pitcher, Brandelyn , Keating, Nancy L. ... - - Breast Cancer Res. Treat. - 2013 Manuscript - Secondary - Primary - Older Adult - CALGB-361002 , CALGB-49907
Association of patient preference for adjuvant chemotherapy (chemo) at baseline (BL) with toxicity, mental health, function, quality of life (QoL) and survival in older women with early stage breast cancer (ESBC) [CALGB 49907 Alliance] Gajra, Ajeet , McCall, Linda , Muss, Hyman B. , Cohen, Harvey J. ... - SABCS - Cancer Res. - 2015 Abstract - Secondary - Primary - Breast - CALGB-49907
The Preference to Receive Chemotherapy and Cancer-related Outcomes in Older Adults with Breast Cancer CALGB 49907 (Alliance) Gajra, Ajeet , McCall, Linda , Muss, Hyman B. , Cohen, Harvey J ... - - J Geriatr Oncol - 2018 Manuscript - Secondary-not-in-original - Primary - Older Adult - CALGB-49907
Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02 Galanis, Evanthia , Anderson, S Keith , Miller, C Ryan ... - - Neuro-oncology - 2018 Manuscript - Primary - Primary - Neuro-Onc - N0874
Phase II trial of vorinostat (VOR) combined with temozolomide (TMZ) and radiation therapy (RT) for newly diagnosed glioblastoma (GBM) (Alliance N0874/ABTC-0902) Galanis, Evanthia , Anderson, S. Keith , Miller, C. Ryan ... - ASCO - J. Clin. Oncol. - 2014 Abstract - Primary - Primary - Neuro-Onc - N0874
Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis Giuliano, Armando E. , Ballman, Karla V. , McCall, Linda ... - - JAMA - 2017 Manuscript - Secondary - Long-Term-Followup - Breast - ACOSOG-Z0011
Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients with Sentinel Lymph Node Metastases: Long-Term Follow-Up from the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial Giuliano, Armando E. , Ballman, Karla , McCall, Linda ... - - Ann. Surg. - 2016 Manuscript - Secondary - Long-Term-Followup - Breast - ACOSOG-Z0011
Association of occult metastases in sentinel lymph nodes and bone marrow with survival of women with early-stage invasive breast cancer Giuliano, Armando E. , Hawes, Debra , Ballman, Karla V. ... - - JAMA - 2011 Manuscript - Primary - Primary - Breast - ACOSOG-Z0010
Ten-Year Survival Results of ACOSOG Z0011 (Alliance) Giuliano, Armando E. , Hunt, Kelly K. , Ballman, Karla. V. ... - ASCO - J. Clin. Oncol. - 2016 Abstract - Secondary - Long-Term-Followup - Breast - ACOSOG-Z0011
Sentinel Lymph Node Dissection With and Without Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis: A Randomized Clinical Trial Giuliano, Armando E. , Hunt, Kelly K. , Ballman, Karla. V. ... - - JAMA - 2011 Manuscript - Primary - Primary - Breast - ACOSOG-Z0011
Locoregional Recurrence after Sentinel Lymph Node Dissection with or without Axillary Dissection in Patients with Sentinel Lymph Node Metastases: Long-term follow-up from the American College of Surgeons Oncology Group (Alliance) Z0011 Randomized Trial Giuliano, Armando E , McCall, Linda , Beitsch, Peter ... - ASA - - 2016 Abstract - Primary - Long-Term-Followup - Breast - ACOSOG-Z0011
Locoregional Recurrence after Sentinel Lymph Node Dissection with or without Axillary Dissection in Patients with Sentinel Lymph Node Metastases: The American College of Surgeons Oncology Group Z0011 Randomized Trial Giuliano, Armando E , McCall, Linda , Beitsch, Peter ... - - Ann. Surg. - 2010 Manuscript - Secondary - Primary - Breast - ACOSOG-Z0011
Accuracy of FDG-PET within the clinical practice of the ACOSOG Z4031 trial to diagnose clinical stage I NSCLC Grogan, Eric L. , Deppen, Stephen A. , Ballman, Karla V. ... - - Ann. Thorac. Surg. - 2014 Manuscript - Secondary-not-in-original - Primary - Respiratory - ACOSOG-Z4031
Randomized Phase II Trial of Capecitabine and Lapatinib with or without IMC-A12 (Cituxumumab) in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab and Chemotherapy: NCCTG N0733 (Alliance). Haddad, Tufia C , He, Jun , O'Sullivan, Ciara C , Chen, Beiyun ... - - Breast Cancer Res Treat - 2021 Manuscript - Primary - Primary - Breast - N0733
Impact of radiation on local regional control in women with node positive breast cancer treated with neoadjuvant chemotherapy and axillary lymph node dissection: Results from ACOSOG 1071 Clinical Trial Haffty, Bruce G. , McCall, Linda M. , Ballman, Karla V. ... - - Int. J. Radiat. Oncol. Biol. Phys. - 2019 Manuscript - Secondary-not-in-original - Primary - Breast - ACOSOG-Z1071
Radiation use and field design in women with node positive breast cancer treated with preoperative systemic therapy and breast surgery including axillary dissection on a prospective clinical trial ACOSOG Z1071 [Alliance] Haffty, Bruce G. , McCall, Linda M. , Ballman, Karla V. ... - ASTRO - Int J Radiation Biol Physics - 2015 Abstract - Secondary-not-in-original - Primary - Breast - ACOSOG-Z1071
Patterns of local-regional management following neoadjuvant chemotherapy in breast cancer: Results from ACOSOG Z1071 (Alliance) Haffty, Bruce G. , McCall, Linda M. , Ballman, Karla V. ... - - Int. J. Radiat. Oncol. Biol. Phys. - 2016 Manuscript - Secondary-not-in-original - Primary - Breast - ACOSOG-Z1071
Impact of radiation on local regional control in women with node positive breast cancer treated with neoadjuvant chemotherapy (NAC) and axillary lymph node dissection (ALND); results from ACOSOG Z1071 (Alliance) Haffty, Bruce , Ballman, Karla , Hunt, Kelly , McCall, Linda ... - ASTRO - Int. J. Radiat. Oncol. Biol. Phys. - 2016 Abstract - Secondary-not-in-original - Primary - Breast - ACOSOG-Z1071
Randomized phase II trial of capecitabine and lapatinib with or without cixutumumab in patients with HER2+ breast cancer previously treated with trastuzumab and an anthracycline and/or a taxane: NCCTG N0733 (Alliance). Haluska, Paul , Bernath, Albert M. , Ballman, Karla V. ... - ASCO - J. Clin. Oncol. - 2014 Abstract - Primary - Primary - Breast - N0733
Local control after resection and adjuvant radiosurgery compared to radiosurgery alone for brain metastasis: Exploratory analysis of Alliance NCCTG N107C Hansen, Chase C. , Ballman, Karla V. , Anderson, S. Keith ... - ASTRO - Int J Radiation Biol Physics - 2020 Abstract - Secondary-not-in-original - Primary - Neuro-Onc - N107C
Factors Associated with Local-Regional Recurrence Following a Negative Sentinel Node Dissection: Results of the ACOSOG Z0010 Trial Hunt, Kelly K. , Ballman, Karla V. , McCall, Linda M. ... - - Ann. Surg. - 2012 Manuscript - Secondary - Primary - Breast - ACOSOG-Z0010
Functional Decline and Resilience among Older Women Receiving Adjuvant Chemotherapy for Breast Cancer Hurria, Arti , Soto-Perez-de-Celis, Enrique , Allred, Jacob B. ... - - J Am Geriatr Soc - 2019 Manuscript - Secondary - Primary - Older Adult - CALGB-361007 , CALGB-49907
CODEL: Phase III study of RT alone, RT plus temozolomide, or temozolomide alone for newly diagnosed 1P/19Q codeleted anaplastic oligodendroglioma patients. Updated analysis from the initial study design (NCCTG N0577, Alliance) Jaeckle, Kurt A. , Ballman, Karla V. , van den Bent, Martin ... - SNO - Neuro-Oncology - 2020 Abstract - Primary - Other - Neuro-Onc - N0577
Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma Jaeckle, Kurt A. , Ballman, Karla , Furth, Alfred ... - - Neurology - 2009 Manuscript - Primary - Primary - Neuro-Onc - N0475
CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design Jaeckle, Kurt A , Ballman, Karla V , van den Bent, Martin ... - - Neuro Oncol - 2020 Manuscript - Primary - Other - Neuro-Onc - N0577
CODEL (Alliance-N0577; EORTC-26081/22086; NRG-1071; NCIC-CEC-2): Phase III randomized study of RT vs. RT+TMZ vs. TMZ for newly diagnosed 1p/19q-codeleted anaplastic glioma. Analysis of patients treated on the original protocol design Jaeckle, Kurt , Vogelbaum, Michael , Ballman, Karla ... - AAN - Neurology - 2016 Abstract - Primary - Comprehensive - Neuro-Onc - N0577
CODEL (Alliance N0577; EORTC 26081/22086 ; NRG 1071; NCIC CEC-2): A Phase III Randomized Intergroup Study for patients (pts) with newly diagnosed 1p/19q codeleted anaplastic glioma. Preliminary analysis of patients treated on the original protocol design with RT vs. RT + concomitant/adjuvant TMZ vs. TMZ alone Jaeckle, Kurt , Voglebaum, Michael , Ballman, Karla ... - SNO - Neuro Oncol - 2015 Abstract - Primary - Comprehensive - Neuro-Onc - N0577
Radiation Field Design in the ACOSOG Z0011 (Alliance) Trial Jagsi, Reshma , Chadha, Manjeet , Moni, Janaki , Ballman, Karla ... - - J. Clin. Oncol - 2014 Manuscript - Secondary - Primary - Breast - ACOSOG-Z0011
Social Support and Its Implications in Older, Early-Stage Breast Cancer Patients in CALGB 49907 (Alliance A171301) Jatoi, Aminah , Muss, Hyman , Allred, Jake B. , Cohen, Harvey J. ... - - Psychooncology - 2016 Manuscript - Secondary - Primary - Older Adult - A171301 , CALGB-49907
Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib Joensuu, Heikki , Eriksson, Mikael , Hall, Kirsten Sundby ... - - Cancer - 2014 Manuscript - Secondary-not-in-original - Primary - GI - ACOSOG-Z9001
Nomogram-Based Estimate of Axillary Nodal Involvement in ACOSOG Z0011 (Alliance): Validation and Association with Radiation Protocol Variations and Outcomes Katz, Matthew S. , McCall, Linda , Ballman, Karla , Haffty, Bruce G. ... - ASTRO - Int J Radiat Oncol Biol Phys - 2018 Abstract - Secondary-not-in-original - Primary - Breast - ACOSOG-Z0011
Nomogram-based estimate of axillary nodal involvement in ACOSOG Z0011 (Alliance): validation and association with radiation protocol variations Katz, Matthew S. , McCall, Linda , Ballman, Karla , Jagsi, Reshma ... - - Breast Cancer Res. Treat. - 2020 Manuscript - Secondary-not-in-original - Primary - Breast - ACOSOG-Z0011
Using ePrognosis to Estimate 2-year All-Cause Mortality in Older Women with Breast Cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503) Kimmick, Gretchen G , Major, Brittny , Clapp, Jonathan , Sloan, Jeff ... - - Breast Cancer Res. Treat. - 2017 Manuscript - Primary - Primary - Older Adult - A151503 , CALGB-369901 , CALGB-49907
Comorbidity, Chemotherapy Toxicity, and Outcomes Among Older Women Receiving Adjuvant Chemotherapy for Breast Cancer on a Clinical Trial: CALGB 49907 and CALGB 361004 (Alliance) Klepin, Heidi D. , Pitcher, Brandelyn N. , Ballman, Karla V. ... - - J Oncol Pract - 2014 Manuscript - Secondary - Primary - Older Adult - CALGB-361004 , CALGB-49907
Feasibility of geriatric assessment for older adults with acute myeloid leukemia (AML) receiving intensive chemotherapy on a cooperative group trial: CALGB 361006 (Alliance). Klepin, Heidi D. , Ritchie, Ellen K. , Sanford, Ben L. ... - ASCO - J. Clin. Oncol. - 2014 Abstract - Primary - Primary - Older Adult - CALGB-361006
Geriatric assessment among older adults receiving intensive therapy for acute myeloid leukemia: Report of CALGB 361006 (Alliance). Klepin, Heidi D , Ritchie, Ellen , Major-Elechi, Brittny ... - - J Geriatr Oncol - 2020 Manuscript - Primary - Primary - Older Adult - CALGB-361006
Improved survival of HER2+ breast cancer patients treated with trastuzumab and chemotherapy is associated with host antibody immunity against the HER2 intracellular domain Knutson, Keith L. , Clynes, Raphael , Shreeder, Barath ... - - Cancer Res. - 2016 Manuscript - Secondary-not-in-original - Meta-Analysis - Breast - N0337 , N98-32-52 , N0938
Associations of HER2-Specific Immunity with Survival During Treatment with Trastuzumab and Chemotherapy in Breast Cancer Knutson, Keith L. , Clynes, Raphael , Yeramian, Patrick ... - ASCO - J. Clin. Oncol. - 2015 Abstract - Secondary-not-in-original - Meta-Analysis - Breast - N0337 , N98-32-52 , N0938
CHOD/BVAM Chemotherapy and Whole-Brain Radiotherapy for Newly Diagnosed Primary Central Nervous System Lymphoma Laack, Nadia N. , O'Neill, Brian Patrick , Ballman, Karla V. ... - - Int. J. Radiat. Oncol. Biol. Phys. - 2011 Manuscript - Primary - Primary - Lymphoma - NCCTG-93-73-51
Central review versus local review of axillary ultrasound prior to and after neoadjuvant chemotherapy: Results from the American College of Surgeons Oncology Group Z1071 trial (Alliance) Le-Petross, H. Carisa , McCall, Linda M. , Hunt, Kelly K. ... - ARRS - - 2019 Abstract - Secondary-not-in-original - Primary - Breast - ACOSOG-Z1071
Axillary Ultrasound Identifies Residual Nodal Disease After Chemotherapy: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance) Le-Petross, Huong T. , McCall, Linda M. , Hunt, Kelly K. ... - - AJR Am J Roentgenol - 2018 Manuscript - Secondary - Primary - Breast - ACOSOG-Z1071
Identifying Risk Factors For Toxicity In Patients With Hormone-Receptor Positive Advanced Breast Cancer Treated With Bevacizumab Plus Letrozole: A CALGB 40503 (Alliance) Correlative Study Li, Daneng , Dickler, Maura N. , McCall, Linda M. , Hahn, Olwen M ... - ASCO - J. Clin. Oncol. - 2016 Abstract - Secondary - Primary - Older Adult - CALGB-40503
Identification of risk factors for toxicity in patients with hormone receptor-positive advanced breast cancer treated with bevacizumab plus letrozole: A CALGB 40503 (Alliance) correlative study. Li, Daneng , McCall, Linda M. , Hahn, Olwen M , Hudis, Clifford A. ... - - Breast Cancer Res. Treat. - 2018 Manuscript - Secondary - Primary - Older Adult - CALGB-40503
Validation of Single-Item Linear Analog Scale Assessment of Quality of Life in Neuro-Oncology Patients Locke, Dona E.C. , Decker, Paul A. , Sloan, Jeff A. , Brown, Paul D. ... - - J Pain Symptom Manage - 2007 Manuscript - Secondary-not-in-original - Comprehensive - Neuro-Onc - N0074 , NCCTG-98-72-51 , NCCTG-98-72-52
Clinical significance of circulating tumor cells (CTCs) in hormone receptor-positive (HR+) metastatic breast cancer (MBC) patients receiving letrozole or letrozole plus bevacizumab: CALGB 40503 (Alliance) Magbanua, Mark Jesus M. , Savenkov, Oleksandr , Asmus, Erik J. ... - ASCO - J. Clin. Oncol. - 2019 Abstract - Secondary-not-in-original - Primary - Breast - CALGB-40503
Clinical significance of circulating tumor cells in hormone receptor-positive metastatic breast cancer patients who received letrozole with or without bevacizumab Magbanua, Mark Jesus M. , Savenkov, Oleksandr , Asmus, Erik J. ... - - Clin. Cancer Res. - 2020 Manuscript - Secondary - Primary - Correl Sci NOS - CALGB-40503
The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial. Meyers, Bryan F , Downey, Robert J , Decker, Paul A ... - - J. Thorac. Cardiovasc. Surg. - 2007 Manuscript - Primary - Primary - Respiratory - ACOSOG-Z0060
Evaluation of the Stage IB Designation of the American Joint Committee on Cancer Staging System in Breast Cancer Mittendorf, Elizabeth A. , Ballman, Karla V. , McCall, Linda M. ... - - J. Clin. Oncol - 2015 Manuscript - Secondary - Primary - Breast - ACOSOG-Z0010
Association Studies of Fcγ Receptor Polymorphisms with Outcome in HER2+ Breast Cancer Patients Treated with Trastuzumab in NCCTG (Alliance) Trial N9831 Norton, Nadine , Olson, Rebecca M. , Pegram, Mark , Tenner, Kathleen ... - - Cancer Immunol Res - 2014 Manuscript - Secondary - Primary - Breast - N9831
Survival implications of variation in the thoroughness of pathologic lymph node examination in American College of Surgeons Oncology Group Z0030 (Alliance) Osarogiagbon, Raymond U. , Decker, Paul A. , Ballman, Karla ... - - Ann. Thorac. Surg. - 2016 Manuscript - Secondary-not-in-original - Primary - Respiratory - ACOSOG-Z0030
Survival implications of variation in the lymph node (LN) count in ACOSOG Z0030 (Alliance) Osarogiagbon, Raymond U. , Decker, Paul , Ballman, Karla ... - IASLC (WCLC) - J Thorac Oncol - 2015 Abstract - Secondary-not-in-original - Primary - Respiratory - ACOSOG-Z0030
Effect of stereotactic radiosurgery compared to whole-brain radiotherapy for limited brain metastasis on long term cognition and quality of life: A pooled analysis of N107C/CEC.3 and N0574 randomized clinical trials (Alliance) Palmer, Joshua D. , Klamer, Brett G. , Ballman, Karla V. ... - ASTRO - Int J Radiation Biol Physics - 2020 Abstract - Secondary-not-in-original - Meta-Analysis - Health Outcome - N0574 , N107C
Analysis of the associations of FC gamma receptor polymorphisms (FCGR3A, FCGR2A, and FCGR2B) with outcome in HER2+ breast cancer patients treated with trastuzumab in NCCTG (Alliance) trial N9831 Pegram, Mark , Norton, Nadine , Tenner, Kathleen , Ballman, Karla L. ... - AACR Adv Br - Mol Cancer Res - 2013 Abstract - Secondary-not-in-original - Primary - Breast - N9831
The relationship between quantitative human epidermal growth factor receptor 2 gene expression by the 21-gene reverse transcriptase polymerase chain reaction assay and adjuvant trastuzumab benefit in Alliance N9831 Perez, Edith A. , Baehner, Frederick L. , Butler, Steven M. ... - - Breast Cancer Res - 2015 Manuscript - Secondary - Primary - Breast - NCCTG-N9831
Stromal tumor infiltrating lymphocytes: In the Alliance N9831 trial STILS are prognostic of chemotherapy benefit but not predictive of trastuzumab benefit Perez, Edith A. , Ballman, Karla V. , Anderson, S. Keith ... - SABCS - Cancer Res. - 2015 Abstract - Secondary-not-in-original - Primary - Breast - N9831
Intrinsic Subtype and Therapeutic Response Among HER2-Positive Breast Tumors from the NCCTG (Alliance) N9831 Trial Perez, Edith A. , Ballman, Karla V. , Mashadi-Hossein, Afshin ... - - J. Natl. Cancer Inst - 2016 Manuscript - Secondary - Primary - Breast - N9831
Intrinsic subtype and therapeutic response among early stage HER2-positive breast tumors from the North Central Cancer Treatment Group (Alliance) N9831 trial Perez, Edith A. , Ballman, Karla V. , Mashadi-Hossein, Afshin ... - SABCS - Cancer Res. - 2016 Abstract - Secondary - Primary - Breast - N9831
Association of Stromal Tumor-Infiltrating Lymphocytes With Recurrence-Free Survival in the N9831 Adjuvant Trial in Patients With Early-Stage HER2-Positive Breast Cancer Perez, Edith A. , Ballman, Karla V. , Tenner, Kathy S. ... - - JAMA Oncol - 2016 Manuscript - Secondary - Primary - Breast - N9831
Association of genomic analysis of immune function genes and clinical outcome in the NCCTG (Alliance) N9831 adjuvant trastuzumab trial. Perez, Edith A. , Thompson, E. Aubrey , Anderson, S. Keith ... - ASCO - J. Clin. Oncol. - 2014 Abstract - Secondary-not-in-original - Primary - Breast - N9831
Genomic Analysis Reveals That Immune Function Genes Are Strongly Linked to Clinical Outcome in the North Central Cancer Treatment Group N9831 Adjuvant Trastuzumab Trial Perez, Edith A. , Thompson, E. Aubrey , Ballman, Karla V. ... - - J. Clin. Oncol - 2015 Manuscript - Secondary - Primary - Breast - N9831
IGF1R Protein Expression is Not Associated with Differential Benefit to Concurrent Trastuzumab in Early-Stage HER2-positive Breast Cancer from the North Central Cancer Treatment Group (Alliance) Adjuvant Trastuzumab Trial N9831 Reinholz, Monica M. , Chen, Beiyun , Dueck, Amylou C. ... - - Clin. Cancer Res. - 2017 Manuscript - Secondary - Primary - Breast - NCCTG-N9831
N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group): Phase III Trial of Post-Operative Stereotactic Radiosurgery (SRS) Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease: Cognitive function of long-term survivors Roberge, David , Ballman, Karla V. , Cerhan, Jane H. ... - SNO - Neuro-Oncology - 2017 Abstract - Secondary - Primary - Neuro-Onc - N107C
CALGB 90601 (Alliance): Randomized, double blind, placebo-controlled phase III trial comparing gemcitabine and cisplatin with bevacizumab or placebo in patients with metastatic urothelial carcinoma Rosenberg, Jonathan , Ballman, Karla , Halabi, Susan , Watt, Colleen ... - ASCO - J Clin Oncol - 2019 Abstract - Primary - Primary - GU - CALGB-90601
Cosmetic outcome following breast conservation surgery and radiation for multiple ipsilateral breast cancer: Data from the Alliance Z11102 Study Rosenkranz, Kari M. , Ballman, Karla V. , McCall, Linda ... - ASBrS - Ann Surg Oncol - 2020 Abstract - Secondary - Primary - Breast - Z11102
The feasibility of breast-conserving surgery for multiple ipsilateral breast cancer: An initial report from ACOSOG Z11102 (Alliance) trial Rosenkranz, Kari M. , Ballman, Karla , McCall, Linda ... - - Ann. Surg. Oncol. - 2018 Manuscript - Secondary - Preliminary - Breast - Z11102
Cosmetic outcomes following breast conservation surgery and radiation for multiple ipsilateral breast cancer: Data from the Alliance Z11102 Study Rosenkranz, Kari M. , Ballman, Karla , McCall, Linda ... - - Ann Surg Oncol - 2020 Manuscript - Secondary - Primary - Breast - Z11102
The feasibility of breast conserving surgery for multiple ipsilateral breast cancer: an initial report from ACOSOG Z11102 (Alliance) trial Rosenkranz, Kari , McCall, Linda , Ballman, Karla ... - ASBrS - Ann. Surg. Oncol. - 2018 Abstract - Secondary - Primary - Breast - Z11102
Changing pattern for HER2 positivity due to updated ASCO/CAP guidelines for HER2 testing and its impact. Shah, Mithun Vinod , Wiktor, Anne E. , Meyer, Reid G. ... - ASCO - J. Clin. Oncol. - 2014 Abstract - Secondary-not-in-original - Primary - Breast - N9831
Cancer registries: a novel alternative to long-term clinical trial follow-up based on results of a comparative study Shi, Qian , You, Y Nancy , Nelson, Heidi , Allen, Mark S ... - - Clin Trials - 2010 Manuscript - Secondary-not-in-original - Primary - Respiratory - ACOSOG-Z0030
A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma: Results from ACOSOG (Alliance) Z1072 Simmons, Rache M. , Ballman, Karla V. , Cox, Charles , Carp, Ned ... - - Ann. Surg. Oncol. - 2016 Manuscript - Primary - Primary - Breast - ACOSOG-Z1072
A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma: Results From ACOSOG (Alliance) Z1072 Simmons, Rache , Ballman, Karla , Cox, Charles , Carp, Ned ... - ASBrS - Ann. Surg. Oncol. - 2014 Abstract - Primary - Primary - Breast - ACOSOG-Z1072
Optimizing whole brain radiotherapy dose and fractionation: Results from a prospective phase III trial (Alliance) Trifiletti, Daniel M. , Ballman, Karla V. , Brown, Paul D. ... - ASTRO - International Journal of Radiation Oncology • Biology • Physics - 2019 Abstract - Secondary-not-in-original - Primary - Neuro-Onc - N107C
Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3). Trifiletti, Daniel M , Ballman, Karla V , Brown, Paul D ... - - Int. J. Radiat. Oncol. Biol. Phys. - 2020 Manuscript - Secondary-not-in-original - Primary - Neuro-Onc - N107C
Phase II evaluation of gefitinib in patients with newly diagnosed grade 4 astrocytoma: Mayo/North Central Cancer Treatment Group study N0074 1 Uhm, Joon H. , Ballman, Karla V. , Wu, Wenting , Giannini, Caterina ... - - Int. J. Radiat. Oncol. Biol. Phys. - 2011 Manuscript - Primary - Primary - Neuro-Onc - N0074
Impact of Race, Ethnicity and BMI on Achievement of Pathologic Complete Response Following Neoadjuvant Chemotherapy for Breast Cancer: A Pooled Analysis of Four Prospective Alliance Clinical Trials (A151426) Warner, Erica T. , Ballman, Karla V. , Strand, Carrie , Boughey, Judy ... - - Breast Cancer Res. Treat. - 2016 Manuscript - Primary - Primary - Disparities - A151426 , ACOSOG-Z1041 , ACOSOG-Z1071 , CALGB-40601 , CALGB-40603
Age, Race, BMI and Pathologic Complete Response Following Neoadjuvant Chemotherapy: An Analysis of Four Alliance Clinical Trials Warner, Erica T. , Ballman, Karla V. , Strand, Carrie ... - ASCO Breast - J. Clin. Oncol. - 2015 Abstract - Primary - Primary - Disparities - A151426 , ACOSOG-Z1031 , ACOSOG-Z1041 , CALGB-40601 , CALGB-40603
Factors associated with residual nodal disease among breast cancer patients treated with neoadjuvant chemotherapy: Results of CALGB 40601 (HER2-positive) and 40603 (triple negative) (Alliance) Weiss, Anna , Campbell, Jordan , Ballman, Karla , Sikov, William ... - SSO - Ann Surg Oncol - 2021 Abstract - Secondary-not-in-original - Primary - Breast - CALGB-40601 , CALGB-40603
Adherence to the National Quality Forum (NQF) Breast Cancer Measures Within Cancer Clinical Trials: A Review From ACOSOG Z0010 Wilke, Lee G. , Ballman, Karla V. , McCall, Linda M. ... - - Ann Surg Oncol - 2010 Manuscript - Secondary-not-in-original - Primary - Breast - ACOSOG-Z0010
PDIGREE: An adaptive phase 3 trial of PD-inhibitor nivolumab and Ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated REnal Cell CancEr (Alliance A031704) Zhang, Tian , Ballman, Karla , Choudhury, Atish , Chen, Ronald C. ... - ASCO - J Clin Oncol - 2020 Abstract - No-Endpoint - Trial-Description-Only - GU - A031704
PDIGREE: An adaptive phase 3 trial of PD-inhibitor nivolumab and Ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated REnal Cell CancEr (Alliance A031704) Zhang, Tian , Ballman, Karla , Choudhury, Atish , Chen, Ronald C. ... - IKCS - J Clin Oncol - 2020 Abstract - Primary - Primary - GU - A031704
PDIGREE: An adaptive phase 3 trial of PD-inhibitor nivolumab and Ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated REnal Cell CancEr (Alliance A031704) Zhang, Tian , Ballman, Karla , Choudhury, Atish , Chen, Ronald C. ... - ASCO - J Clin Oncol - 2019 Abstract - No-Endpoint - Trial-Description-Only - GU - A031704
A Pooled Analysis of the Cardiac Events in the Trastuzumab Adjuvant Trials de Azambuja, Evandro , Ponde, Noam , Procter, Marion , Rastogi, Priya ... - - Breast Cancer Res. Treat. - 2020 Manuscript - Secondary-not-in-original - Primary - Breast - NCCTG-N9831